MILLER STRATEGIES, LLC

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · represents biopharmaceutical research companies

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Medicare/Medicaid

Medicare and healthcare policy issues as they relate to drug pricing, CMMI, and Medicare Part D; including rebate system reforms

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.